Real-World First-Line Serplulimab-Based Immunochemotherapy for Extensive-Stage Small Cell Lung Cancer: The Multicenter ASTRUM-005R Study

被引：0
|
作者：
Wu, L. [1 ]
Hu, C. [2 ]
Su, W. [3 ]
Yu, Y. [4 ]
Hong, W. [5 ]
Liu, Z. [6 ,8 ]
Su, H. [7 ]
Liu, Z. [6 ,8 ]
Wang, C. [9 ]
Pu, Q. [10 ]
Guo, H. [11 ]
Min, X. [12 ]
Chen, Y. [3 ]
Zhu, H. [13 ]
Luo, T. [14 ]
机构：
[1] Hunan Canc Hosp, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China
[3] Chinese Acad Med Sci, Canc Hosp, Shanxi Hosp, Taiyuan, Peoples R China
[4] Harbin Med Univ Canc Hosp, Harbin, Peoples R China
[5] Univ Chinese Acad Sci, Dept Chest Oncol, Canc Hosp, Beijing, Peoples R China
[6] Southern Med Univ, Affiliated Hosp 10, Dongguan Peoples Hosp, Dongguan, Peoples R China
[7] Air Force Med Univ, Xian, Peoples R China
[8] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[9] Shandong First Med Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[10] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[12] AN HUI CHEST Hosp, Hefei, Anhui, Peoples R China
[13] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[14] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Extensive-stage small cell lung cancer; PD-1; inhibitor; Serplulimab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13A.07
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [21] Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
    Xie, Zhaoliang
    Liu, Jingru
    Wu, Min
    Wang, Xiaohan
    Lu, Yuhan
    Han, Chunyan
    Cong, Lei
    Li, Jisheng
    Meng, Xue
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [22] Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer
    Igata, Fumiyasu
    Inoue, Hiroyuki
    Ikeda, Takato
    Nakao, Akira
    Ebi, Noriyuki
    Fujita, Masaki
    ANTICANCER RESEARCH, 2024, 44 (07) : 3175 - 3183
  • [23] Atezolizumab plus chemotherapy followed by atezolizumab plus anlotinib in the first-line treatment for extensive-stage small cell lung cancer: A multicenter, single-arm, prospective real-world study
    Pan, Y.
    Qian, X.
    Zhou, H.
    Jin, W.
    Chen, J.
    Wang, Y.
    Zhang, Z.
    Liu, H.
    Jin, Y.
    Jiang, F.
    Liu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1071 - S1071
  • [24] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Horn, L.
    Mansfield, A. S.
    Szczesna, A.
    Havel, L.
    Krzakowski, M.
    Hochmair, M. J.
    Huemer, F.
    Losonczy, G.
    Johnson, M. L.
    Nishio, M.
    Reck, M.
    Mok, T.
    Lam, S.
    Shames, D. S.
    Liu, J.
    Ding, B.
    Lopez-Chavez, A.
    Kabbinavar, F.
    Lin, W.
    Sandler, A.
    Liu, S. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2220 - 2229
  • [25] Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in extensive-stage small cell lung cancer: a real-world retrospective analysis
    Zhang, Qi
    Wang, Qian
    Wang, Mengsen
    Liu, Xiaomeng
    Han, Dan
    Sun, Hongfu
    Zhao, Chengwei
    Liu, Chengxin
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
  • [26] A real-world study of anlotinib in combination with PD-L1 inhibitors plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer.
    Chen, Size
    Lin, Yiguang
    Song, Minghan
    Dong, Jiayi
    Lijuan, Shao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer
    West, W
    Birch, R
    Schnell, F
    Hainsworth, J
    Tongol, J
    Campos, L
    ONCOLOGIST, 2003, 8 (01): : 76 - 82
  • [28] A Real-World Study of the Efficacy of Immune-Checkpoint Inhibitors for Extensive-Stage Small Cell Lung Cancer
    Liu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E411 - E411
  • [29] Treatment patterns in extensive-stage small cell lung cancer: A retrospective real-world data study.
    Ganti, Apar Kishor
    Katranji, Kenan
    Seal, Brian S.
    Brannman, Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [30] Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
    Zugazagoitia, Jon
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 671 - +
12345